Abstract:Loss of sensory hair cells from exposure to certain licit drugs, such as aminoglycoside antibiotics, can result in permanent hearing damage. Exogenous application of the neurotrophic molecule hepatocyte growth factor (HGF) promotes neuronal cell survival in a variety of contexts, including protecting hair cells from aminoglycoside ototoxicity. HGF itself is not an ideal therapeutic due to a short half-life and limited blood-brain barrier permeability. MM-201 is a chemically stable, blood-brain barrier permeable, synthetic HGF mimetic that serves as a functional ligand to activate the HGF receptor and its downstream signaling cascade. We previously demonstrated that MM-201 robustly protects zebrafish lateral line hair cells from aminoglycoside ototoxicity. Here, we examined the ability of MM-201 to protect mammalian sensory hair cells from aminoglycoside damage to further evaluate MM-201's clinical potential. We found that MM-201 exhibited dose-dependent protection from neomycin and gentamicin ototoxicity in mature mouse utricular explants. MM-201's protection was reduced following inhibition of mTOR, a downstream target of HGF receptor activation, implicating the activation of endogenous intracellular substrates by MM-201 as critical for the observed protection. We then asked if MM-201 altered the bactericidal properties of aminoglycosides. Using either plate or liquid growth assays we found that MM-201 did not alter the bactericidal efficacy of aminoglycoside antibiotics at therapeutically relevant concentrations. We therefore assessed the protective capacity of MM-201 in an in vivo mouse model of kanamycin ototoxicity. In contrast to our in vitro data, MM-201 did not attenuate kanamycin ototoxicity in vivo. Further, we found that MM-201 was ototoxic to mice across the dose range tested here. These data suggest species- and tissue-specific differences in otoprotective capacity. Next generation HGF mimetics are in clinical trials for neurodegenerative diseases and show excellent safety profiles, but neither preclinical studies nor clinical trials have examined hearing loss as a potential consequence of pharmaceutical HGF activation. Further research is needed to determine the consequences of systemic MM-201 application on the auditory system.

A Novel Active Peptide from Rapana Venosa Protects Against Gentamicin-Induced Sensory Hair Cell Loss in Zebrafish

Theophylline Alleviates Gentamicin-Induced Cytotoxicity to Sensory Hair Cells by Maintaining HDAC2 Expression

A mitochondrial targeting tetrapeptide Bendavia protects lateral line hair cells from gentamicin exposure

Naringin attenuates cisplatin- and aminoglycoside-induced hair cell injury in the zebrafish lateral line via multiple pathways

Mitochondria-targeting nanomedicine: An effective and potent strategy against aminoglycosides-induced ototoxicity

Mitochondrial-derived peptides, HNG and SHLP3, protect cochlear hair cells against gentamicin

Novel compounds protect auditory hair cells against gentamycin-induced apoptosis by maintaining the expression level of H3K4me2

Rapamycin Protects Spiral Ganglion Neurons from Gentamicin-Induced Degeneration In Vitro

EGb 761 (Ginkgo biloba) protects cochlear hair cells against ototoxicity induced by gentamicin via reducing reactive oxygen species and nitric oxide-related apoptosis

Protective mechanism of ferulic acid against neomycin‐induced ototoxicity in zebrafish

Hepatocyte growth factor mimetic confers protection from aminoglycoside-induced hair cell death in vitro

Protective effects of minocycline and MDL 28170 in gentamicin ototoxicity

Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector-mediated GDNF Gene Transfer into the Cochlea.

Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector|[ndash]|mediated GDNF Gene Transfer Into the Cochlea

Galangin prevents aminoglycoside-induced ototoxicity by decreasing mitochondrial production of reactive oxygen species in mouse cochlear cultures

Mangiferin alleviates cisplatin-induced ototoxicity in sensorineural hearing loss

ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity

Chemical screen in zebrafish lateral line identified compounds that ameliorate neomycin-induced ototoxicity by inhibiting ferroptosis pathway

Peperphentonamine Hydrochloride Protects Against Gentamicin-Induced Cochlea Damage by Lowering Cochlear Caspase-3 Expression in Guinea Pigs

The Ganglioside Monosialotetrahexosylganglioside Protects Auditory Hair Cells Against Neomycin-Induced Cytotoxicity Through Mitochondrial Antioxidation: An in vitro Study

Tetrandrine Prevents Neomycin-Induced Ototoxicity by Promoting Steroid Biosynthesis